Literature DB >> 15207727

Reduced cell replication and induction of apoptosis by advanced glycation end products in rat Schwann cells.

Hiromi Sekido1, Takeshi Suzuki, Takahito Jomori, Masayoshi Takeuchi, Chihiro Yabe-Nishimura, Soroku Yagihashi.   

Abstract

We investigated the effects of advanced glycation end products (AGEs) derived from glucose, glyceraldehyde, and glycolaldehyde (designated as AGE-1, -2, and -3, respectively) on the viability, replication rate, and cytokine production of cultured Schwann cells. AGE-2 and -3, but not AGE-1, induced apoptosis, and significantly decreased the viability measured by MTT assay. The decrease was prevented completely by antioxidant alpha-lipoic acid and was prevented partially by p38 mitogen-activated protein kinase inhibitor SB202190. The decrease in mitochondrial membrane potential by AGE-2 and -3 was also observed. In addition, AGE-2 and -3 significantly suppressed the replication rate as shown by reduced bromodeoxyuridine uptake, whereas they enhanced the release of TNF-alpha and IL-1beta into the medium and activated nuclear factor-kappaB. The effects of AGE-1 on these measures were equivocal. The series of events elicited by AGE-2 and -3 may be responsible for some of the aspects of pathogenetic mechanisms in patients with diabetic neuropathy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207727     DOI: 10.1016/j.bbrc.2004.05.159

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Schwann cells as a therapeutic target for peripheral neuropathies.

Authors:  Helmar C Lehmann; Ahmet Höke
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-12       Impact factor: 4.388

Review 2.  Diabetic peripheral neuropathy: should a chaperone accompany our therapeutic approach?

Authors:  Kevin L Farmer; Chengyuan Li; Rick T Dobrowsky
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

3.  Sural nerve pathology in diabetic patients with minimal but progressive neuropathy.

Authors:  R A Malik; S Tesfaye; P G Newrick; D Walker; S M Rajbhandari; I Siddique; A K Sharma; A J M Boulton; R H M King; P K Thomas; J D Ward
Journal:  Diabetologia       Date:  2005-02-24       Impact factor: 10.122

4.  Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways.

Authors:  Mani Alikhani; Zoubin Alikhani; Coy Boyd; Christine M MacLellan; Markos Raptis; Rongkun Liu; Nicole Pischon; Philip C Trackman; Louis Gerstenfeld; Dana T Graves
Journal:  Bone       Date:  2006-10-24       Impact factor: 4.398

5.  Enhanced angiotensin II-mediated central sympathoexcitation in streptozotocin-induced diabetes: role of superoxide anion.

Authors:  Kaushik P Patel; William G Mayhan; Keshore R Bidasee; Hong Zheng
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-17       Impact factor: 3.619

Review 6.  Mechanisms of distal axonal degeneration in peripheral neuropathies.

Authors:  Christopher R Cashman; Ahmet Höke
Journal:  Neurosci Lett       Date:  2015-01-21       Impact factor: 3.046

7.  A Comparative Study of Xi's Tendon Gangrene (Nonischemic Type of Diabetic Foot) and Gangrene (Diabetic Foot Ischemic Type).

Authors:  Linfeng Peng; Yuzheng Wang; Cheng Zhao; Zhiguo Zhao; Qi Fei; Pengchao Xin; Hongtao Xu; Yemin Cao
Journal:  Comput Math Methods Med       Date:  2022-06-28       Impact factor: 2.809

Review 8.  Immortalized adult rodent Schwann cells as in vitro models to study diabetic neuropathy.

Authors:  Kazunori Sango; Hiroko Yanagisawa; Shizuka Takaku; Emiko Kawakami; Kazuhiko Watabe
Journal:  Exp Diabetes Res       Date:  2011-06-13

Review 9.  Cutaneous innervation in impaired diabetic wound healing.

Authors:  Nicole C Nowak; Daniela M Menichella; Richard Miller; Amy S Paller
Journal:  Transl Res       Date:  2021-05-23       Impact factor: 10.171

Review 10.  AGE-RAGE synergy influences programmed cell death signaling to promote cancer.

Authors:  Bhargav N Waghela; Foram U Vaidya; Kishu Ranjan; Abu Sufiyan Chhipa; Budhi Sagar Tiwari; Chandramani Pathak
Journal:  Mol Cell Biochem       Date:  2020-10-06       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.